Klebsiella pneumoniae subsp. pneumoniae
PTCC No:
1792
Other collection No. ::
ATCC 700603, DSM 26371, CCUG 45421, LMG 20218
Medium:
Culture condition:
37 °C, aerobic
Information:
<- ATCC <-- JM Swenson <-- MJ Ferraro <-- G Jacoby <-- H Dalton, Strain K6. Isolated from urine of hospitalized patient, Richmond, Virginia, United States of America. Produces beta-lactamase SHV-18. Quality control strain. Resistant to ampicillin Resistant to aztreonam. Resistant to cefoxitin. Resistant to cefpodoxime. Resistant to ceftazidime. Resistant to chloramphenicol. Resistant to piperacillin. Resistant to tetracycline Sensitive to amoxicillin-clavulanate. Sensitive to cefepime. Intermediate resistance for cefotaxime. Sensitive to ciprofloxacin. Sensitive to imipenem. Sensitive to piperacillin-tazobactam. Intermediate resistance for Tobramycin. Sensitive to trimethoprim-sulfamethoxazole. Susceptibility disc testing. Susceptibility testing. Control for extended-spectrum beta-lactamase production. Used for respiratory research.
Literature:
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - 9th Edition. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M2-A9. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - 7th Edition. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M7-A8. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard - 2nd Edition. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M31-A3. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M100-S20, 2007. Rasheed JK, et al. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18. Antimicrob. Agents Chemother. 44: 2382-2388, 2000. PubMed: 10952583. ETEST ESBL STRIP. bioMerieux.
Supplied as:
Freeze-dried
Risk group:
2